Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-24
SponsorPhuc Huu Phan

About this trial

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract infection in young children, and a substantial proportion of severe cases occur in previously healthy infants. The gut-lung axis suggests that gut microbiome composition may modulate respiratory immune responses. This prospective observational study in Vietnam will compare gut microbiome profiles and systemic immune cytokine responses between infants with severe RSV infection and those with mild RSV infection, aiming to identify microbiome-immune signatures associated with disease severity.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

250 Participants
are grouped into 1 trial group

Sponsors and collaborators

Phuc Huu Phan

Lead sponsor

National Children's Hospital, Vietnam

Sponsor institution